These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
59 related articles for article (PubMed ID: 1504581)
1. In vivo changes of heterogeneity of mouse peritoneal macrophages induced by cis-diamminedichloroplatinum (II) (cis-DDP) and related platinum compounds. Peschke T; Schröer HP; Augsten K Exp Toxicol Pathol; 1992 Jun; 44(3):154-9. PubMed ID: 1504581 [TBL] [Abstract][Full Text] [Related]
2. Effect of several fixatives on the density of concanavalin A binding sites of murine peritoneal macrophages determined by fluorescence microscopy and X-ray microanalysis. Peschke T; Gabert A; Wollweber L; Augsten K Acta Histochem Suppl; 1986; 33():201-6. PubMed ID: 3090628 [TBL] [Abstract][Full Text] [Related]
3. Differential toxicity of cis- and trans-diamminedichloroplatinum(II) toward mammalian cells: lack of influence of any difference in the rates of loss of their DNA-bound adducts. Roberts JJ; Friedlos F Cancer Res; 1987 Jan; 47(1):31-6. PubMed ID: 3791217 [TBL] [Abstract][Full Text] [Related]
4. Effect of cis-diamminedichloroplatinum(II) and other platinum compounds on the RNA polymerase reaction. Ganeva R; Spassovska N; Genchev D Cytobios; 1994; 77(309):81-6. PubMed ID: 8020247 [TBL] [Abstract][Full Text] [Related]
5. Effect of selenium in combination with cis-diamminedichloroplatinum(II) in the treatment of murine fibrosarcoma. Berry JP; Pauwells C; Tlouzeau S; Lespinats G Cancer Res; 1984 Jul; 44(7):2864-8. PubMed ID: 6539165 [TBL] [Abstract][Full Text] [Related]
6. Antitumor, nephrotoxic and clastogenic effect of cis-DDP with DDTC or NAC. Konstantinov S; Topashka-Ancheva M; Karaivanova M; Zoneva G; Galova I Neoplasma; 1994; 41(5):253-8. PubMed ID: 7854494 [TBL] [Abstract][Full Text] [Related]
7. Selective protection against cis-diamminedichloroplatinum(II)-induced toxicity in kidney, gut, and bone marrow by diethyldithiocarbamate. Bodenner DL; Dedon PC; Keng PC; Katz JC; Borch RF Cancer Res; 1986 Jun; 46(6):2751-5. PubMed ID: 3009000 [TBL] [Abstract][Full Text] [Related]
8. Monitoring of interaction products of cis-diamminedichloroplatinum(II) and cis-diammine(1,1-cyclobutanedicarboxylato)platinum(II) with DNA in cells from platinum-treated cancer patients. Terheggen PM; Dijkman R; Begg AC; Dubbelman R; Floot BG; Hart AA; den Engelse L Cancer Res; 1988 Oct; 48(19):5597-603. PubMed ID: 3046743 [TBL] [Abstract][Full Text] [Related]
9. Cis DDP in combination with selenium and sulfur. Subcellular effect in kidney cells. Electron microprobe study. Berry JP; Lespinats G J Submicrosc Cytol Pathol; 1988 Jan; 20(1):59-65. PubMed ID: 3370622 [TBL] [Abstract][Full Text] [Related]
10. Antitumor activity, induction of cross-resistance, and nephrotoxicity of a new platinum analogue, cis-1,1-diaminomethylcyclohexaneplatinum(II) sulfate, and of cis-diamminedichloroplatinum(II) in an immunocytoma model in the LOU/M rat. de Jong WH; Steerenberg PA; Vos JG; Bulten EJ; Verbeek F; Kruizinga W; Ruitenberg EJ Cancer Res; 1983 Oct; 43(10):4927-34. PubMed ID: 6683993 [TBL] [Abstract][Full Text] [Related]
11. The interaction of platinum antitumour drugs with mouse liver mitochondria. Rosen M; Figliomeni M; Simpkins H Int J Exp Pathol; 1992 Feb; 73(1):61-74. PubMed ID: 1315566 [TBL] [Abstract][Full Text] [Related]
12. Effect of para-aminobenzoic acid on the pharmacokinetics and urinary excretion of cis-diamminedichloroplatinum(II) in rats. Esposito M; Vannozzi M; Viale M; Pellecchia C; Civalleri D; Gogioso L Anticancer Res; 1995; 15(6B):2541-7. PubMed ID: 8669820 [TBL] [Abstract][Full Text] [Related]
13. The endocytosis of asbestos by mouse peritoneal macrophages and its long-term effect on iron accumulation and labyrinth formation. Koerten HK; Brederoo P; Ginsel LA; Daems WT Eur J Cell Biol; 1986 Mar; 40(1):25-36. PubMed ID: 3009191 [TBL] [Abstract][Full Text] [Related]
14. Differential uptake of cis-diamminedichloroplatinum (II) by sensitive and resistant murine L1210 leukemia cells. Waud WR Cancer Res; 1987 Dec; 47(24 Pt 1):6549-55. PubMed ID: 3677093 [TBL] [Abstract][Full Text] [Related]
15. Interaction of two second generation platinum antitumor drugs with mouse thymocytes. Simpkins H; Pearlman LF Cancer Res; 1986 Mar; 46(3):1433-9. PubMed ID: 3510724 [TBL] [Abstract][Full Text] [Related]
16. Effect of cis- and trans-dichlorodiammineplatinum(II) on human tumor cell proliferation in diffusion chambers in vivo. Ambrose KR; Lowrey JS Cancer Res; 1982 May; 42(5):1769-73. PubMed ID: 7039818 [TBL] [Abstract][Full Text] [Related]
17. Effect of diethyldithiocarbamate on cis-diamminedichloroplatinum(II)-induced cytotoxicity, DNA cross-linking, and gamma-glutamyl transpeptidase inhibition. Bodenner DL; Dedon PC; Keng PC; Borch RF Cancer Res; 1986 Jun; 46(6):2745-50. PubMed ID: 2870800 [TBL] [Abstract][Full Text] [Related]
18. [Intraperitoneal administration of cis-diamminedichloroplatinum (II) for peritoneal carcinomatosis caused by gastric cancers]. Kurihara N; Kumai K; Kubota T; Furukawa T; Yamamoto T; Shimada A; Shibata S; Saikawa Y; Ogawa S; Murayama Y Gan To Kagaku Ryoho; 1993 Aug; 20(11):1645-8. PubMed ID: 8373238 [TBL] [Abstract][Full Text] [Related]
19. Increased removal of DNA-bound platinum in a human ovarian cancer cell line resistant to cis-diamminedichloroplatinum(II). Masuda H; Tanaka T; Matsuda H; Kusaba I Cancer Res; 1990 Mar; 50(6):1863-6. PubMed ID: 2306738 [TBL] [Abstract][Full Text] [Related]
20. Correlation between cell killing by cis-diamminedichloroplatinum(II) in six mammalian cell lines and binding of a cis-diamminedichloroplatinum(II)-DNA antiserum. Terheggen PM; Emondt JY; Floot BG; Dijkman R; Schrier PI; den Engelse L; Begg AC Cancer Res; 1990 Jun; 50(12):3556-61. PubMed ID: 2340504 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]